3Okada Y. Proteinases and matrix degradation. In Kelley WN, Ruddy S, Harris ED,eds. Textbook of theumatology [ J ]. Philadelphia: WB Saunders,2000(6) :55 -72.
4Zucker S, Hymovitz M, Conner C, et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues: clinical experimental applications. Ann NY Aead Sei, 1999 (878) :212 -227.
5Lydyard PM, Edwards JC. The pathophysiology of rheumatoid ar2thritis [J]. Clin Exp Rheumatol,1994,12( 11 ) :55 -58.
6Fosang AJ, Neame PJ, Last K, et al. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathep sin B [J]. J B iol Chem , 1992(267):19470- 19474.
7Tsuboi H, Matsui Y, Yamane S, et al. Tartrate resistant acid phos - phatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage [ J ]. Annals of the Reum atic D is, 2003,62(3) :196 -204.
8Ishiguro N, Ito T, O bata K, et al. Determination of stromelysin - 1, 72 K da type IV collagenase, tissue inhibitor of metalloproteinase - 1 ( TIMP - 1 ), and TIMP - 2 in synovial fluid and serum from patients with rheumatoid arthritis [ J ]. J Rheumatol, 1996 (23) : 1599 - 1604 .
9Kliniuk PA, Sierakowski S, latosiewicz R, et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in differenthistological variants of rheumatoid synovitis[ J ]. Rheumatology ( Oxford ), 2002(41 ) :78 -87.
